Impact of Prolonged Impella 5.5 Support on Post-Transplant Outcomes: An Institutional Study

Area of Science:

• Cardiovascular Medicine
• Transplantation Surgery
• Medical Devices

Background:

• Microaxial flow pumps, such as the Impella 5.5, are critical for advanced cardiogenic shock patients awaiting heart transplantation.
• Limited data exists on how the duration of mechanical circulatory support impacts outcomes after heart transplant.

Purpose of the Study:

• To evaluate and compare post-transplantation outcomes in patients bridged to heart transplant with the Impella 5.5, stratified by device support duration.

Main Methods:

• A retrospective analysis included patients successfully bridged to heart transplant using the Impella 5.5.
• Patients were categorized into two groups based on support duration: ≤ 14 days and > 14 days.
• Outcomes assessed included 1-year mortality, index admission complications, graft rejection, and 1-year rehospitalization rates.

Main Results:

• No significant differences in pre-transplant clinical status were observed between the short-term (<14 days) and long-term (>14 days) support groups.
• Hospital length of stay and rates of discharge to home were similar across both support duration cohorts.
• Despite high 1-year rehospitalization rates (75%), 1-year survival was excellent (96%) and comparable between groups.

Conclusions:

• Extended use of the Impella 5.5 microaxial flow pump appears to be a safe and effective bridging strategy for heart transplantation.
• Comparable post-transplant outcomes suggest that longer support duration does not adversely affect patient results.